Evonetix raises £9 million for gene synthesis

A two-year old company targeting the market for synthetic biology has raised £9 million to advance a new gene synthesis platform. Evonetix Ltd of Cambridge UK has technology that enables the parallel synthesis of DNA on silicon arrays.